Medical device manufacturers are under increasing pressure to bring products to global markets faster while maintaining strict regulatory compliance. Under the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), organizations must provide accurate, understandable information in the languages required by each target market. At the same time, the volume of content requiring translation continues to grow: from Instructions for Use (IFUs) and labeling to software interfaces, training materials, and post-market surveillance documentation. As a result, many manufacturers are exploring AI translation for medical devices to accelerate multilingual content delivery and reduce costs.<\/p>\n\n\n\n
But can AI translation be used for medical devices without compromising compliance, patient safety, or market access?<\/strong><\/p>\n\n\n\n The answer is yes, but only when AI translation for medical devices is implemented within a robust quality and regulatory framework. In highly regulated industries such as medical devices, AI should be viewed as an efficiency tool rather than a replacement for expert human review.<\/p>\n\n\n\n In this article, we’ll examine the opportunities and risks of AI translation for medical devices, explain what MDR, IVDR, and the EU AI Act mean for manufacturers, and outline best practices for building a compliant translation strategy.<\/p>\n\n\n\n <\/p>\n\n\n\nTable of Contents<\/h2>